Most recently, it's been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to a wide array of endogenous opioids. Not like most opioid receptors, this receptor functions as being a https://elizabethv328kbw2.blogpixi.com/profile